The Wistar Institute, a world leader in cancer, immunology, and infectious disease research, announces the appointment of Qingsheng Li, Ph.D., as professor in the HIV Cure and Viral Diseases Center…
PHILADELPHIA — (May 28, 2025) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joshua Friedman, M.D., Ph.D., to its B…
PHILADELPHIA — (May 22, 2025) — Researchers at The Wistar Institute have identified a previously unknown mechanism by which viruses can reprogram mitochondrial structure to silence immune responses a…
PHILADELPHIA — (April 30, 2025) —The Wistar Institute, a world leader in cancer, immunology, and infectious disease research, announces the appointment of Xiaoyu (Ariel) Zhou, Ph.D., as assistant pro…
PHILADELPHIA — (April 9, 2025) —The Wistar Institute’s Joseph Salvino, Ph.D., — in collaboration with Elton Zeqiraj, Ph.D., of The University of Leeds and Roger Greenberg, M.D., Ph.D., of The Perelma…
PHILADELPHIA — (March 21, 2025) — Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., in collaboration with scientists in the laboratory of Norbert Pardi, Ph.D., at the University of Pe…
PHILADELPHIA — (March 20, 2025) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome three new members to its Board of Tr…
PHILADELPHIA — (March 10, 2025) — The Wistar Institute’s Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the p…
PHILADELPHIA — (Feb. 28, 2024) — The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells…
PHILADELPHIA — (February 28, 2025) —The Wistar Institute welcomes its newest faculty member, Colby Maldini, Ph.D., who joins Wistar’s HIV Cure and Viral Diseases Center as a Caspar Wistar Fellow…
